Wonder what this means for a pump user? I actually find that Novolog works pretty well as expected, though Symlin really helps things along.
Dr. Jean L. Ardilouze, a professor of medicine at University of Sherbrooke in Quebec, Canada, and three colleagues presented “In Obese Subjects with Type 2 Diabetes, Are Short Acting Insulin Analogues That Short?”
Diabetes – Short-Acting Insulin Isn’t Short for Most Type 2s
Leave a Reply